Relmada Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.2k | 1.6k | 2.01 |
| 2025-06-30 | $3.7k | 6.2k | 0.60 |
| 2024-12-31 | $395 | 760 | 0.52 |
| 2024-06-30 | $8.3k | 2.8k | 3.00 |
| 2024-03-31 | $45k | 9.8k | 4.65 |
| 2023-09-30 | $5.1k | 1.7k | 3.00 |
| 2023-06-30 | $12k | 4.8k | 2.46 |
| 2023-03-31 | $10k | 4.6k | 2.25 |
| 2022-12-31 | $84k | 24k | 3.50 |
| 2022-09-30 | $32k | 852 | 37.56 |
| 2022-06-30 | $28k | 1.5k | 19.06 |
| 2022-03-31 | $6.0k | 208 | 28.85 |
| 2021-12-31 | $28k | 1.2k | 22.82 |
| 2021-09-30 | $18k | 681 | 26.43 |
| 2021-06-30 | $31k | 1.0k | 30.00 |
| 2021-03-31 | $63k | 1.8k | 35.04 |
| 2020-12-31 | $35k | 1.2k | 29.94 |
| 2020-09-30 | $462k | 12k | 37.62 |
| 2020-06-30 | $40k | 901 | 44.40 |
| 2019-12-31 | $84k | 2.1k | 39.20 |